The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Mono Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
Mono vaccines reduce the number of shots your child needs while protecting against only one serious diseases
The global Mono Vaccine market size is expected to reach US$ 20410 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Mono Vaccine in various end use industries. The expanding demands from the Adults and Children, are propelling Mono Vaccine market. Meningococcal Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Japanese Encephalitis Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mono Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mono Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mono Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mono Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mono Vaccine covered in this report include GSK, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India and Biokangtai, etc.
The global Mono Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Global Mono Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mono Vaccine market, Segment by Type:
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Global Mono Vaccine market, by Application
Adults
Children
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Mono Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Mono Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Mono vaccines reduce the number of shots your child needs while protecting against only one serious diseases
The global Mono Vaccine market size is expected to reach US$ 20410 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Mono Vaccine in various end use industries. The expanding demands from the Adults and Children, are propelling Mono Vaccine market. Meningococcal Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Japanese Encephalitis Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mono Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mono Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mono Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mono Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mono Vaccine covered in this report include GSK, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India and Biokangtai, etc.
The global Mono Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Global Mono Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mono Vaccine market, Segment by Type:
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Global Mono Vaccine market, by Application
Adults
Children
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Mono Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Mono Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Mono Vaccine Market Overview
1.1 Mono Vaccine Product Overview
1.2 Mono Vaccine Market Segment by Type
1.2.1 Meningococcal Vaccine
1.2.2 Japanese Encephalitis Vaccine
1.2.3 Yellow Fever Vaccine
1.2.4 Hepatitis Vaccine
1.2.5 Cholera Vaccine
1.2.6 Other
1.3 Global Mono Vaccine Market Size by Type
1.3.1 Global Mono Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Mono Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Mono Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Mono Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Mono Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Mono Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Mono Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Mono Vaccine Sales Breakdown by Type (2018-2023)
2 Global Mono Vaccine Market Competition by Company
2.1 Global Top Players by Mono Vaccine Sales (2018-2023)
2.2 Global Top Players by Mono Vaccine Revenue (2018-2023)
2.3 Global Top Players by Mono Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Mono Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Mono Vaccine Market Competitive Situation and Trends
2.5.1 Mono Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Mono Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mono Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Mono Vaccine Market
2.8 Key Manufacturers Mono Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Mono Vaccine Status and Outlook by Region
3.1 Global Mono Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Mono Vaccine Historic Market Size by Region
3.2.1 Global Mono Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Mono Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Mono Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Mono Vaccine Forecasted Market Size by Region
3.3.1 Global Mono Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Mono Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Mono Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Mono Vaccine by Application
4.1 Mono Vaccine Market Segment by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Mono Vaccine Market Size by Application
4.2.1 Global Mono Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Mono Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Mono Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Mono Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Mono Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Mono Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Mono Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Mono Vaccine Sales Breakdown by Application (2018-2023)
5 North America Mono Vaccine by Country
5.1 North America Mono Vaccine Historic Market Size by Country
5.1.1 North America Mono Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Mono Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Mono Vaccine Sales in Value by Country (2018-2023)
5.2 North America Mono Vaccine Forecasted Market Size by Country
5.2.1 North America Mono Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Mono Vaccine Sales in Value by Country (2024-2029)
6 Europe Mono Vaccine by Country
6.1 Europe Mono Vaccine Historic Market Size by Country
6.1.1 Europe Mono Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Mono Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Mono Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Mono Vaccine Forecasted Market Size by Country
6.2.1 Europe Mono Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Mono Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Mono Vaccine by Region
7.1 Asia-Pacific Mono Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Mono Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Mono Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Mono Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Mono Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Mono Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Mono Vaccine Sales in Value by Region (2024-2029)
8 Latin America Mono Vaccine by Country
8.1 Latin America Mono Vaccine Historic Market Size by Country
8.1.1 Latin America Mono Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Mono Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Mono Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Mono Vaccine Forecasted Market Size by Country
8.2.1 Latin America Mono Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Mono Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Mono Vaccine by Country
9.1 Middle East and Africa Mono Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Mono Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Mono Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Mono Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Mono Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Mono Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Mono Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Mono Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Mono Vaccine Products Offered
10.1.5 GSK Recent Development
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Company Information
10.2.2 Sanofi Pasteur Introduction and Business Overview
10.2.3 Sanofi Pasteur Mono Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Pasteur Mono Vaccine Products Offered
10.2.5 Sanofi Pasteur Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Mono Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Mono Vaccine Products Offered
10.3.5 Merck Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Mono Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Mono Vaccine Products Offered
10.4.5 Pfizer Recent Development
10.5 CNBG
10.5.1 CNBG Company Information
10.5.2 CNBG Introduction and Business Overview
10.5.3 CNBG Mono Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 CNBG Mono Vaccine Products Offered
10.5.5 CNBG Recent Development
10.6 Sanofi Pasteur MSD
10.6.1 Sanofi Pasteur MSD Company Information
10.6.2 Sanofi Pasteur MSD Introduction and Business Overview
10.6.3 Sanofi Pasteur MSD Mono Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sanofi Pasteur MSD Mono Vaccine Products Offered
10.6.5 Sanofi Pasteur MSD Recent Development
10.7 Serum Institute of India
10.7.1 Serum Institute of India Company Information
10.7.2 Serum Institute of India Introduction and Business Overview
10.7.3 Serum Institute of India Mono Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Serum Institute of India Mono Vaccine Products Offered
10.7.5 Serum Institute of India Recent Development
10.8 Biokangtai
10.8.1 Biokangtai Company Information
10.8.2 Biokangtai Introduction and Business Overview
10.8.3 Biokangtai Mono Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Biokangtai Mono Vaccine Products Offered
10.8.5 Biokangtai Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Mono Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Mono Vaccine Industrial Chain Analysis
11.4 Mono Vaccine Market Dynamics
11.4.1 Mono Vaccine Industry Trends
11.4.2 Mono Vaccine Market Drivers
11.4.3 Mono Vaccine Market Challenges
11.4.4 Mono Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Mono Vaccine Distributors
12.3 Mono Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
